These innovations are part of a broader strategy to leverage cloud technology for scalable AI development, aiming to improve patient outcomes and operational efficiency.

GE HealthCare has launched its AI Innovation Lab, aimed at advancing early-concept AI projects to transform healthcare.

As part of this initiative, the company introduced CareIntellect for Oncology, a cloud-first application designed to unify multi-modal patient data into a single view.

CareIntellect will initially focus on prostate and breast cancer, with plans to expand its offerings and potentially incorporate AI solutions from partner organizations.

The platform aggregates both structured and unstructured patient data, including medical images and records, and assists clinicians with clinical note summarization and treatment history.

Chelsea Vane, vice president of digital products at GE HealthCare, noted that the application can significantly reduce the time oncologists spend identifying relevant clinical trials for patients.

With over $19.6 billion in sales for 2023, GE HealthCare ranks as Chicago's 15th largest public company, showcasing its significant impact in the healthcare sector.

Another key project, Health Companion, employs agentic AI to support clinical decision-making by simulating a multi-disciplinary care team.

Additionally, GE HealthCare has submitted a 510(k) application to the FDA for an AI feature that interprets fetal heart rates, enhancing monitoring accuracy during pregnancy.

In parallel, a project is underway to create a full-body X-ray foundation model using 1.2 million anonymized images to assist with diagnostics and reduce administrative burdens.

This initiative also includes improving maternal and infant care through collaboration with health systems and utilizing generative AI to streamline data searches.

Dr. Taha Kass-Hout from GE Healthcare emphasized that currently, only 3% of hospital data is utilized, highlighting the need for solutions like CareIntellect.